|Last Price||Today's Change||52-Week Range||Trading Volume|
|49.12||0.20 (+0.41%)||41.11 - 57.49||5.0 million (Below Avg)|
Market data as of 4:00PM 07/22/14. Quotes are delayed by at least 15 min.
Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to Assess Effectiveness and Safety of Eliquis® (apixaban) in Patients with NVAF Undergoing Cardioversion
07/17/2014 8:06 AM ET
Bristol-Myers Squibb Announces Plans for Third Quarter Submission of a Biologics License Application for Opdivo® (nivolumab), an Investigational PD-1 Immune Checkpoint Inhibitor, for Previously Treated Advanced Melanoma
07/10/2014 7:30 AM ET